Hanx Biopharmaceuticals (Wuhan) Co., Ltd. announced that, effective 2 June 2026, its principal place of business in Hong Kong has been relocated to Room 1918, 19/F, Lee Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong.
The company confirmed that its telephone number, email address and website remain unchanged following the move.
The announcement was authorised by the Board of Directors and signed by Chairman and Executive Director Dr. Zhang Faming on the date of the notice.